Compare EML & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EML | ARCT |
|---|---|---|
| Founded | 1858 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9M | 163.4M |
| IPO Year | 1995 | 2019 |
| Metric | EML | ARCT |
|---|---|---|
| Price | $25.52 | $14.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | 9.7K | ★ 1.1M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | ★ 185.40 | 20.00 |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $248,970,345.00 | $82,031,000.00 |
| Revenue This Year | $19.05 | N/A |
| Revenue Next Year | N/A | $12.77 |
| P/E Ratio | $24.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.61 | $5.50 |
| 52 Week High | $29.91 | $24.14 |
| Indicator | EML | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 51.75 |
| Support Level | $24.10 | $6.47 |
| Resistance Level | $27.16 | $17.75 |
| Average True Range (ATR) | 1.44 | 1.37 |
| MACD | -0.14 | -0.39 |
| Stochastic Oscillator | 34.27 | 20.66 |
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.